More About Ludwig Center for Cancer Immunotherapy Minus iconIcon indicating subtraction, or that the element can be closed. Plus IconIcon indicating addition, or that the element can be opened. Arrow (down) icon.An arrow icon, usually indicating that the containing element can be opened and closed.

Mission and Scope

In recent years, progress in biomedical research and technology has provided unprecedented opportunities to explore new therapies that — when used on their own or in combination with other types of treatment — might prevent or slow the progression of tumors by harnessing the inherent antitumor activities of a patient’s immune system.

The Ludwig Center for Cancer Immunotherapy promotes and facilitates the integration of laboratory and clinical investigation of such immunotherapies through a number of activities, for example by:

  • Developing experimental immunotherapy strategies in preclinical models
  • Translating such therapies from preclinical investigation to clinical application
  • Monitoring immune responses in cancer patients as a means to improve the understanding of basic mechanisms by which cells of the immune system respond to tumors
  • Analyzing clinical data to inform basic and translational research
  • Developing and optimizing probes for targeted diagnostics and radioimmunotherapy